About the Company - Alkem Laboratories Ltd
Alkem Laboratories Ltd. is a Public Limited Listed company incorporated on 08/08/1973 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L00305MH1973PLC174201 and registration number is 174201. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 8829.81 Cr. and Equity Capital is Rs. 23.91 Cr. for the Year ended 31/03/2022.
Management |
---|
Name | Position Held |
---|
Mr. Basudeo N Singh | Executive Chairman |
Mr. Sandeep Singh | Managing Director |
Mrs. Madhurima Singh | Executive Director |
Mr. Balmiki Prasad Singh | Executive Director |
Mr. Mritunjay Kumar Singh | Executive Director |
Mr. Sarvesh Singh | Executive Director |
Mr. Arun Kumar Purwar | Independent Director |
Ms. Sangeeta Singh | Independent Director |
Ms. Sudha Ravi | Independent Director |
Dr. Dheeraj Sharma | Independent Director |
Mr. Narendra Kumar Aneja | Independent Director |
Mr. Sujjain Suresh Talwar | Independent Director |
Alkem Laboratories Ltd. Share Price Update |
---|
Share Price | Value |
---|
Today | ₹4,551.95 |
Previous Day | ₹4,554.40 |
Basic Stock Data of Alkem Laboratories Ltd
Market Cap | 54,364 Cr. |
---|
Current Price | 4,547 |
---|
High / Low | 4,640/2,835 |
---|
Stock P/E | 36.2 |
---|
Book Value | 823 |
---|
Dividend Yield | 0.55 % |
---|
ROCE | 13.7 % |
---|
ROE | 12.1 % |
---|
Face Value | 2.00 |
---|
Alkem Laboratories Ltd Quarterly Results
Month | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|
Sales | 2,363 | 2,318 | 2,192 | 2,731 | 2,800 | 2,619 | 2,484 | 2,576 | 3,079 | 3,041 | 2,903 | 2,968 | 3,440 |
Expenses | 1,762 | 1,789 | 1,901 | 2,138 | 2,176 | 2,121 | 2,147 | 2,373 | 2,625 | 2,442 | 2,549 | 2,579 | 2,693 |
Operating Profit | 600 | 529 | 291 | 593 | 624 | 498 | 337 | 203 | 454 | 599 | 353 | 389 | 747 |
OPM % | 25% | 23% | 13% | 22% | 22% | 19% | 14% | 8% | 15% | 20% | 12% | 13% | 22% |
Other Income | 36 | 96 | 46 | 47 | 42 | 54 | 6 | 51 | 51 | 45 | -34 | 66 | 6 |
Interest | 18 | 13 | 11 | 13 | 12 | 11 | 17 | 26 | 25 | 27 | 29 | 30 | 30 |
Depreciation | 70 | 69 | 69 | 71 | 73 | 77 | 83 | 76 | 77 | 78 | 78 | 72 | 74 |
Profit before tax | 548 | 543 | 258 | 556 | 582 | 464 | 243 | 152 | 402 | 539 | 212 | 353 | 648 |
Tax % | 12% | 15% | 3% | 14% | 4% | -15% | 55% | 13% | 14% | 15% | 68% | 18% | 5% |
Net Profit | 482 | 464 | 249 | 480 | 559 | 533 | 108 | 131 | 348 | 460 | 68 | 288 | 615 |
EPS in Rs | 39.48 | 37.72 | 20.07 | 39.15 | 45.52 | 43.96 | 9.00 | 10.68 | 27.67 | 38.03 | 5.94 | 23.98 | 51.90 |
Alkem Laboratories Ltd Quarterly Chart
Alkem Laboratories Ltd Profit & Loss
Alkem Laboratories Ltd Profit & Loss Yearly Chart
Alkem Laboratories Ltd Growth
|
Compounded Sales Growth |
---|
10 Years:: | 17% |
5 Years:: | 13% |
3 Years:: | 12% |
TTM:: | 15% |
Alkem Laboratories Ltd Growth
|
Compounded Profit Growth |
---|
10 Years:: | 11% |
5 Years:: | 11% |
3 Years:: | -2% |
TTM:: | 37% |
Alkem Laboratories Ltd Growth
|
Stock Price CAGR |
---|
10 Years:: | % |
5 Years:: | 18% |
3 Years:: | 18% |
1 Year:: | 46% |
Alkem Laboratories Ltd Growth
|
Return on Equity |
---|
10 Years:: | 18% |
5 Years:: | 18% |
3 Years:: | 18% |
Last Year:: | 12% |
Alkem Laboratories Ltd Balance Sheet
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 |
---|
Equity Capital | 12 | 12 | 12 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 |
Reserves | 1,802 | 2,160 | 2,567 | 2,975 | 3,668 | 4,444 | 4,840 | 5,415 | 6,137 | 7,353 | 8,614 | 9,021 | 9,819 |
Borrowings | 1,007 | 1,552 | 1,128 | 1,306 | 658 | 659 | 998 | 944 | 1,616 | 1,792 | 2,668 | 1,397 | 1,441 |
Other Liabilities | 644 | 547 | 604 | 986 | 1,184 | 1,440 | 1,803 | 1,824 | 2,169 | 2,351 | 2,763 | 3,315 | 3,642 |
Total Liabilities | 3,466 | 4,271 | 4,311 | 5,291 | 5,534 | 6,568 | 7,664 | 8,208 | 9,946 | 11,519 | 14,069 | 13,757 | 14,926 |
Fixed Assets | 919 | 1,072 | 1,170 | 1,374 | 1,450 | 1,797 | 2,284 | 2,530 | 2,908 | 2,793 | 2,902 | 2,683 | 2,905 |
CWIP | 0 | 0 | 0 | 111 | 172 | 299 | 381 | 493 | 363 | 393 | 339 | 323 | 181 |
Investments | 323 | 478 | 588 | 481 | 509 | 553 | 444 | 324 | 261 | 333 | 371 | 622 | 626 |
Other Assets | 2,224 | 2,721 | 2,553 | 3,325 | 3,403 | 3,918 | 4,555 | 4,861 | 6,413 | 8,000 | 10,457 | 10,129 | 11,214 |
Total Assets | 3,466 | 4,271 | 4,311 | 5,291 | 5,534 | 6,568 | 7,664 | 8,208 | 9,946 | 11,519 | 14,069 | 13,757 | 14,926 |
Alkem Laboratories Ltd Reserves and Borrowings Chart
Alkem Laboratories Ltd Cash Flow
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|
Cash from Operating Activity | 159 | 78 | 290 | 325 | 726 | 471 | 266 | 780 | 585 | 1,265 | 1,111 | 1,682 |
Cash from Investing Activity | -246 | -403 | 353 | -235 | 205 | -294 | -351 | -318 | -737 | -995 | -1,433 | 120 |
Cash from Financing Activity | -11 | 356 | -600 | -52 | -927 | -138 | 85 | -379 | 79 | -272 | 380 | -1,761 |
Net Cash Flow | -98 | 31 | 44 | 39 | 3 | 40 | 0 | 82 | -73 | -2 | 58 | 42 |
|
Alkem Laboratories Ltd Financial Efficiency Indicators Chart
Alkem Laboratories Ltd Share Holding Pattern
Month | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|
Promoters | 62.43% | 60.16% | 58.84% | 58.84% | 57.13% | 57.13% | 57.14% | 57.16% | 57.16% | 57.16% | 57.16% | 56.74% |
FIIs | 4.08% | 4.42% | 4.50% | 5.33% | 5.40% | 5.41% | 5.67% | 4.46% | 4.41% | 4.44% | 5.63% | 6.03% |
DIIs | 12.96% | 13.20% | 14.49% | 13.99% | 13.94% | 14.14% | 14.10% | 15.73% | 16.44% | 16.69% | 16.34% | 17.63% |
Public | 20.53% | 22.22% | 22.17% | 21.84% | 23.53% | 23.32% | 23.09% | 22.65% | 21.99% | 21.69% | 20.85% | 19.58% |
No. of Shareholders | 98,554 | 95,294 | 93,540 | 87,392 | 86,881 | 81,869 | 84,104 | 79,721 | 76,516 | 73,440 | 66,790 | 69,442 |
Alkem Laboratories Ltd Shareholding Pattern Chart
No. of Alkem Laboratories Ltd Shareholders
Alkem Laboratories Ltd Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) |
---|
DSP Mid Cap Fund | 1738353 | 4.21 | 633.26 |
Nippon India Growth Fund | 790000 | 1.48 | 284.87 |
Axis Midcap Fund | 639250 | 1.02 | 230.51 |
SBI Large & Midcap Fund | 560000 | 1.39 | 204 |
UTI Mid Cap Fund | 479907 | 1.97 | 174.82 |
ICICI Prudential Long Term Equity Fund | 475902 | 1.54 | 173.36 |
Kotak Emerging Equity Fund - Regular Plan | 472218 | 0.52 | 172.02 |
ICICI Prudential Value Discovery Fund | 441205 | 0.49 | 160.72 |
DSP Flexi Cap Fund | 441106 | 1.79 | 160.69 |
DSP Equity Opportunities Fund | 426942 | 1.75 | 155.53 |
Alkem Laboratories Ltd ROCE Trend
Alkem Laboratories Ltd EPS Trend
Alkem Laboratories Ltd Key Financial Ratios
Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 |
---|
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Basic EPS (Rs.) | 82.31 | 137.63 | 132.57 | 94.26 | 63.61 |
Diluted EPS (Rs.) | 82.31 | 137.63 | 132.57 | 94.26 | 63.61 |
Cash EPS (Rs.) | 110.18 | 165.98 | 158.29 | 117.28 | 80.87 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 789.21 | 740.05 | 632.20 | 527.73 | 466.08 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 789.21 | 740.05 | 632.20 | 527.73 | 466.08 |
Revenue From Operations / Share (Rs.) | 970.24 | 889.52 | 741.53 | 697.98 | 615.41 |
PBDIT / Share (Rs.) | 152.70 | 185.33 | 181.98 | 131.96 | 100.58 |
PBIT / Share (Rs.) | 126.73 | 159.90 | 159.01 | 110.82 | 84.42 |
PBT / Share (Rs.) | 109.14 | 154.27 | 154.09 | 105.38 | 79.85 |
Net Profit / Share (Rs.) | 84.22 | 140.55 | 135.32 | 96.14 | 64.71 |
NP After MI And SOA / Share (Rs.) | 82.32 | 137.65 | 132.58 | 94.28 | 63.61 |
PBDIT Margin (%) | 15.73 | 20.83 | 24.54 | 18.90 | 16.34 |
PBIT Margin (%) | 13.06 | 17.97 | 21.44 | 15.87 | 13.71 |
PBT Margin (%) | 11.24 | 17.34 | 20.77 | 15.09 | 12.97 |
Net Profit Margin (%) | 8.67 | 15.80 | 18.24 | 13.77 | 10.51 |
NP After MI And SOA Margin (%) | 8.48 | 15.47 | 17.87 | 13.50 | 10.33 |
Return on Networth / Equity (%) | 10.88 | 19.05 | 21.48 | 18.29 | 13.98 |
Return on Capital Employeed (%) | 15.07 | 20.63 | 24.01 | 19.77 | 16.84 |
Return On Assets (%) | 7.15 | 11.69 | 13.75 | 11.33 | 9.26 |
Long Term Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.01 | 0.04 |
Total Debt / Equity (X) | 0.15 | 0.29 | 0.22 | 0.25 | 0.16 |
Asset Turnover Ratio (%) | 0.86 | 0.71 | 0.69 | 0.77 | 0.76 |
Current Ratio (X) | 2.35 | 1.76 | 1.92 | 1.70 | 1.90 |
Quick Ratio (X) | 1.65 | 1.13 | 1.28 | 1.14 | 1.22 |
Inventory Turnover Ratio (X) | 1.33 | 1.33 | 1.23 | 1.39 | 1.23 |
Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 21.12 | 31.82 | 23.58 |
Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 18.00 | 25.99 | 18.80 |
Earning Retention Ratio (%) | 0.00 | 0.00 | 78.88 | 68.18 | 76.42 |
Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 82.00 | 74.01 | 81.20 |
Interest Coverage Ratio (%) | 17.00 | 42.31 | 36.92 | 24.25 | 22.01 |
Interest Coverage Ratio (Post Tax) (%) | 11.34 | 33.37 | 28.46 | 18.67 | 15.16 |
Enterprise Value (Cr.) | 39790.80 | 43453.40 | 33002.69 | 28474.91 | 21316.35 |
EV / Net Operating Revenue (X) | 3.43 | 4.09 | 3.72 | 3.41 | 2.90 |
EV / EBITDA (X) | 21.80 | 19.61 | 15.17 | 18.05 | 17.73 |
MarketCap / Net Operating Revenue (X) | 3.50 | 4.07 | 3.74 | 3.34 | 2.85 |
Retention Ratios (%) | 0.00 | 0.00 | 78.87 | 68.17 | 76.41 |
Price / BV (X) | 4.49 | 5.01 | 4.49 | 4.52 | 3.85 |
Price / Net Operating Revenue (X) | 3.50 | 4.07 | 3.74 | 3.34 | 2.85 |
EarningsYield | 0.02 | 0.03 | 0.04 | 0.04 | 0.03 |
Alkem Laboratories Ltd Profitability Ratios (%)
Alkem Laboratories Ltd Liquidity Ratios
Alkem Laboratories Ltd Liquidity Ratios (%)
Alkem Laboratories Ltd Interest Coverage Ratios (%)
Alkem Laboratories Ltd Valuation Ratios
Strength and Weakness of Alkem Laboratories Ltd Stock
Unable to fetch valid data for stock valuation.